143 related articles for article (PubMed ID: 12913229)
1. Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex.
Nojima H; Takeda-Shitaka M; Kurihara Y; Kamiya K; Umeyama H
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):923-8. PubMed ID: 12913229
[TBL] [Abstract][Full Text] [Related]
2. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
Murthy VL; Stern LJ
Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
[TBL] [Abstract][Full Text] [Related]
3. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
4. Dynamic characteristics of a peptide-binding groove of human HLA-A2 class I MHC molecules: normal mode analysis of the antigen peptide-class I MHC complex.
Nojima H; Takeda-Shitaka M; Kurihara Y; Adachi M; Yoneda S; Kamiya K; Umeyama H
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1209-14. PubMed ID: 12237537
[TBL] [Abstract][Full Text] [Related]
5. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
6. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
[TBL] [Abstract][Full Text] [Related]
8. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
Negroni MP; Stern LJ
PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
10. The MHC class II-associated invariant chain-derived peptide clip binds to the peptide-binding groove of class II molecules.
Wu S; Gorski J
Mol Immunol; 1996; 33(4-5):371-7. PubMed ID: 8676888
[TBL] [Abstract][Full Text] [Related]
11. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
Kropshofer H; Bohlinger I; Max H; Kalbacher H
Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
[TBL] [Abstract][Full Text] [Related]
12. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
Busch R; Cloutier I; Sékaly RP; Hämmerling GJ
EMBO J; 1996 Jan; 15(2):418-28. PubMed ID: 8617217
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Brown JH; Jardetzky TS; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
Nature; 1993 Jul; 364(6432):33-9. PubMed ID: 8316295
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):734-8. PubMed ID: 8570625
[TBL] [Abstract][Full Text] [Related]
15. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.
Zarutskie JA; Sato AK; Rushe MM; Chan IC; Lomakin A; Benedek GB; Stern LJ
Biochemistry; 1999 May; 38(18):5878-87. PubMed ID: 10231540
[TBL] [Abstract][Full Text] [Related]
16. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
[TBL] [Abstract][Full Text] [Related]
17. High-throughput engineering and analysis of peptide binding to class II MHC.
Jiang W; Boder ET
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13258-63. PubMed ID: 20622157
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
[TBL] [Abstract][Full Text] [Related]
19. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition.
Tate KM; Lee C; Edelman S; Carswell-Crumpton C; Liblau R; Jones PP
Int Immunol; 1995 May; 7(5):747-61. PubMed ID: 7547702
[TBL] [Abstract][Full Text] [Related]
20. Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the beta chain.
Etongué-Mayer P; Langlois MA; Ouellette M; Li H; Younes S; Al-Daccak R; Mourad W
Eur J Immunol; 2002 Jan; 32(1):50-8. PubMed ID: 11754003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
